Search Results

CEO Miguel Martin discusses lessons learned from Aurora Cannabis’ past and how the firm’s transformation plan will impact the future.

The major stakeholders pushing Congress to enact sweeping federal marijuana reform just got bigger with the formation of a new band of businesses and industry experts who believe legalization is a foregone conclusion and that the real prize will be shaping a nationwide MJ regulatory framework.

A subsidiary of cigarette maker British American Tobacco and Atlantic Canada-based cannabis producer Organigram signed a 220 million Canadian dollar ($175 million) strategic collaboration with a focus on research and product development.

Global pharma company Jazz Pharmaceuticals has reached an agreement to buy U.K.-based GW Pharmaceuticals, one of the largest medical cannabinoid businesses in the world, for $7.2 billion in cash and stock, the drugmakers announced Wednesday.

When Aphria bought a notable U.S. craft brewer this week for about $300 million, the Canadian cannabis producer flipped one industry narrative upside down.

The appearance of Pabst Blue Ribbon’s iconic blue logo on cannabis-infused beverage packaging might be a sign that the beverage category, which often struggles for market share, is poised for speedy growth in North America and perhaps beyond.

Canada’s adult-use cannabis market has expanded rapidly since the legalization of marijuana in October 2018. Monthly retail sales figures in May signaled an annual market worth around $1.6 billion (CA$2.2 billion)—or roughly the size of Colorado’s recreational and medical markets combined.

It was a week of reckoning for many in the cannabis industry as the coronavirus outbreak has become the straw that broke the cash-challenged camel’s back – or the material adverse change companies are using to change plans made in different times.